Ethical questions in gene therapyIigo de Miguel BeriainJessica AlmqvistPrecision Medicine for Investigators, Practitioners and Providers
This part concludes that far more reasons exist to commend fetal gene therapy than to reject it, given its limits and modest social and economic priority. The second part responds to specific ethical questions that must be raised about any protocol for human gene therapy. These questions and ...
In contemporary ethical discussion widespread concern about the potential risks of genetic engineering is raising new and fundamental questions about our r... E Agius,S Busuttil - 《Bioethics》 被引量: 37发表: 1998年 Ethical Issues in Social Intervention In contemporary ethical discussion widespread...
New ethical questions have arisen from our ability to intervene in the structure of the genome. Responsible use of this technique requires ethical evaluati... John C. Polkinghorne - 《Trends in Biotechnology》 被引量: 37发表: 2000年 Zeroing in on ethical issues in nanotechnology Setting aside ex...
There is a complete lack of restraint to shape the development of the field; the basic scientists are not addressing Nature's 70 MOHAMMAD AFZAL, YASIR HASAN SIDDIQUE, TANVEER BEG AND ALI M. BHAT questions, or diverting research towards higher orders of...
Geriatric patients with advanced kidney disease provoked two ethical questions generated by two realities: (1) The 33 million Americans aged 65 years or older in 2003 will, by the year 2030, increase to 70 million.3 (2) More than 1 million Americans over the age of 65 years currently have...
Although direct access to medical testing increases consumer autonomy and supports self-determination, it raises a number of questions. In 2004, the ACMG issued a statement concluding that "due to the complexities of genetic testing and counseling, the self- ordering of genetic tests by patients ...
Want to thank TFD for its existence?Tell a friend about us, add a link to this page, or visitthe webmaster's page for free fun content. Link to this page: Facebook Twitter
Genome-wide diagnostic testing inevitably means that far more genetic information about the patient is revealed than is necessary for answering the clinical question. Among other things, this raises questions about the feasibility of informed consent, the possibility to shape the 'right not to know'...
questions about international use become relevant, since patients could take their cells to countries where there are differences in regulations or there is less oversight for cellular therapies; case in point, one private adult stem cell bank sends their clients to receive MSC therapy in a hospital...